ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease
June 26, 2019Voxelotor Improves Hemoglobin Levels in Sickle Cell Disease. -
GBT heads to FDA with sickle cell drug voxelotor
December 05, 2018Global Blood Therapeutics (GBT) has persuaded the FDA to accept biomarker data from a phase III trial of sickle cell disease drug voxelotor as part of a filing for accelerated approval..... -
FDA agrees accelerated approval pathway for GBT’s voxelotor
December 05, 2018The US Food and Drug Administration (FDA) has granted San Francisco-based Global Blood Therapeutics (GBT)’s sickle cell disease (SCD) therapy voxelotor an accelerated approval under the subpart H pathway.
Pharma Sources Insight January 2025
